Understanding Patient Perspectives on the Risks of Ionizing Radiation Used for Medical Imaging

Completed

• Conditions: Neuroblastoma; Testicular Cancer; Breast Cancer; Lung Cancer; Colon Cancer

• Registration Number: NCT01482741
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

Risks from imaging-related radiation exposure have become a popular topic in the media. Because these tests are commonly applied to patients at a cancer center, it is important to understand what patients know, how they feel about what they know, where they get their information, and how satisfied they are with available risk-benefit communication on this topic.

The purpose of this study is to understand how cancer patients perceive risks and benefits of diagnostic radiation and their satisfaction with healthcare communication on this topic.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-11
• Study First Submitted: 2011-11-28
• Study First Submitted QC: 2011-11-28
• Study First Posted: 2011-12-01
• Status Verified: 2015-06
• Primary Completion: 2015-06
• Study Completion: 2015-06
• Last Update Submitted: 2015-06-24
• Last Update Posted: 2015-06-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• English-language fluent
• 18 years of age, or older
• Provide informed consent
• Group 1: Patients undergoing chemotherapy for Stage IV colorectal carcinoma.
• Group 2: Parents of pediatric patients who have undergone treatment for stage 1-3 neuroblastoma.
• Group 3: Women who have undergone treatment for early stage breast cancer within the preceding 6 months.
• Group 4: Men undergoing surveillance imaging after treatment for testicular cancer.
• Group 5: Patients currently or previously enrolled in the MSKCC lung cancer screening program.
• Group 6: Patients enrolled in or eligible for the thoracic survivorship program.

Exclusion Criteria

• Participants who don't speak English

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
characterize participant knowledge, attitudes	2 years	about imaging radiation, information sources, and satisfaction with risk-benefit communication.

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center; 🇺🇸 New York, New York, United States